Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Apr 25

PMID 35462989

Authors

Liala Moschetti

Silvia Piantoni

Enrico Vizzardi

Edoardo Sciatti

Mauro Riccardi

Franco Franceschini

Ilaria Cavazzana

Affiliations

Soon will be listed here.

Abstract

This review describes the complex interplay between inflammation, vasculopathy and fibrosis that involve the heart and peripheral small vessels, leading to endothelial stiffness, vascular damage, and early aging in patients with systemic lupus erythematosus and systemic sclerosis, which represents two different models of vascular dysfunction among systemic autoimmune diseases. In fact, despite the fact that diagnostic methods and therapies have been significantly improved in the last years, affected patients show an excess of cardiovascular mortality if compared with the general population. In addition, we provide a complete overview on the new techniques which are used for the evaluation of endothelial dysfunction in a preclinical phase, which could represent a new approach in the assessment of cardiovascular risk in these patients.

Citing Articles

Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases.

Biscetti F, Polito G, Rando M, Nicolazzi M, Eraso L, DiMuzio P Int J Mol Sci. 2025; 26(2).

PMID: 39859250 PMC: 11765428. DOI: 10.3390/ijms26020535.

Transcriptomic analysis of + non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways.

Terrones M, Op de Beeck K, Van Camp G, Vandeweyer G, Mateiu L Front Oncol. 2024; 14:1408697.

PMID: 39737401 PMC: 11683107. DOI: 10.3389/fonc.2024.1408697.

The 330 risk loci known for systemic lupus erythematosus (SLE): a review.

Laurynenka V, Harley J Front Lupus. 2024; 2.

PMID: 39624492 PMC: 11609870. DOI: 10.3389/flupu.2024.1398035.

A Novel Preclinical Murine Model of Systemic Lupus Erythematosus-Like Cardiovascular Disease.

McCrorey M, Hawkins K, Semenikhina M, Bernstein M, Lacey R, Colvert C ACR Open Rheumatol. 2024; 6(12):891-899.

PMID: 39364830 PMC: 11638127. DOI: 10.1002/acr2.11744.

Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus.

Bergkamp S, Bergkamp N, Wahadat M, Gruppen M, Nassar-Sheikh Rashid A, Tas S Lupus Sci Med. 2024; 11(2).

PMID: 39242108 PMC: 11381702. DOI: 10.1136/lupus-2024-001190.

References

Scambi C, Ugolini S, Jokiranta T, De Franceschi L, Bortolami O, La Verde V . The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study. PLoS One. 2015; 10(2):e0114856. PMC: 4319765. DOI: 10.1371/journal.pone.0114856. View

Saygin D, Highland K, Tonelli A . Microvascular involvement in systemic sclerosis and systemic lupus erythematosus. Microcirculation. 2018; 26(3):e12440. PMC: 6041191. DOI: 10.1111/micc.12440. View

Manetti M, Pratesi S, Romano E, Bellando-Randone S, Rosa I, Guiducci S . Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. PLoS One. 2017; 12(8):e0183102. PMC: 5552290. DOI: 10.1371/journal.pone.0183102. View

Bellik L, Musilli C, Vinci M, Ledda F, Parenti A . Human mature endothelial cells modulate peripheral blood mononuclear cell differentiation toward an endothelial phenotype. Exp Cell Res. 2008; 314(16):2965-74. DOI: 10.1016/j.yexcr.2008.07.016. View

Holt C, Lindsey N, Moult J, Malia R, Greaves M, Hume A . Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol. 1989; 78(3):359-65. PMC: 1534812. View

Mauro D, Nerviani A . Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities. Rev Recent Clin Trials. 2018; 13(3):192-198. DOI: 10.2174/1574887113666180314091831. View

Wilhelm A, Rhoads J, Wade N, Major A . Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice. Ann Rheum Dis. 2014; 74(4):778-85. PMC: 4083014. DOI: 10.1136/annrheumdis-2013-203759. View

Martin M, Martinez C, Arnaud L, Weber J, Poindron V, Blaison G . Association of antiphospholipid antibodies with active digital ulceration in systemic sclerosis. RMD Open. 2019; 5(2):e001012. PMC: 6802995. DOI: 10.1136/rmdopen-2019-001012. View

Ruaro B, Bruni C, Wade B, Baratella E, Confalonieri P, Antonaglia C . Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?. Front Physiol. 2021; 12:710298. PMC: 8542764. DOI: 10.3389/fphys.2021.710298. View

10.

Cannarile F, Valentini V, Mirabelli G, Alunno A, Terenzi R, Luccioli F . Cardiovascular disease in systemic sclerosis. Ann Transl Med. 2015; 3(1):8. PMC: 4293487. DOI: 10.3978/j.issn.2305-5839.2014.12.12. View

11.

Thanei S, Vanhecke D, Trendelenburg M . Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways. Clin Immunol. 2015; 160(2):180-7. DOI: 10.1016/j.clim.2015.06.014. View

12.

Agca R, Heslinga S, Rollefstad S, Heslinga M, McInnes I, Peters M . EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2016; 76(1):17-28. DOI: 10.1136/annrheumdis-2016-209775. View

13.

Campos-Lopez B, Meza-Meza M, Parra-Rojas I, Ruiz-Ballesteros A, Vizmanos-Lamotte B, Munoz-Valle J . Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study. Clin Immunol. 2020; 222:108637. DOI: 10.1016/j.clim.2020.108637. View

14.

Tektonidou M, Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis P, Protogerou A . Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis. Autoimmun Rev. 2017; 16(3):308-312. DOI: 10.1016/j.autrev.2017.01.009. View

15.

Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y . Defective vasculogenesis in systemic sclerosis. Lancet. 2004; 364(9434):603-10. DOI: 10.1016/S0140-6736(04)16853-0. View

16.

Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R . Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med. 2000; 6(10):1183-6. DOI: 10.1038/80533. View

17.

Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C . Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 2006; 54(8):2605-15. DOI: 10.1002/art.22035. View

18.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

19.

Petri M, Barr E, Magder L . Development of a systemic lupus erythematosus cardiovascular risk equation. Lupus Sci Med. 2019; 6(1):e000346. PMC: 6827738. DOI: 10.1136/lupus-2019-000346. View

20.

Park J, Kim J, Moon J, Ahn E, Lee E, Lee E . Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis. Arthritis Res Ther. 2017; 18(1):306. PMC: 5203709. DOI: 10.1186/s13075-016-1204-x. View